Skip to main content
. 2015 Aug 7;21(29):8804–8810. doi: 10.3748/wjg.v21.i29.8804

Table 3.

Response rate to immunomodulators and anti-tumor necrosis factor for severe or refractory microscopic colitis

Number of patients Mean age (yr) Treatment Duration of therapy Response rate
Münch et al[22], 2013 46 59 Azathioprine or 6-MP 2 mg/kg per day Variable, 1-57 mo 41%
Pardi et al[30], 2001 9 62 Azathioprine or 6-MP 2 mg/kg per day 26 mo 56%
Münch et al[21], 2013 9 62 Methotrexate 15-25 mg/wk 12 wk 0%
Esteve et al[25], 2011 4 59 Infliximab 5 mg/kg at 0, 2, 6 wk then every 6-8 wk intravenously Variable, 5-14 mo 75%
Münch et al[26], 2012 3 55 Adalimumab induction1 then 40 mg subcutaneously every 2 wk 6 wk 66%
Pola et al[24], 2013 1 58 Infliximab 5 mg/kg at 0, 2, 6 wk then every 8 wk intravenously 6 mo 100%
1

Adalimumab induction: 160 mg (week 0), 80 mg (week 2), and 40 mg (week 4).